<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin-top:0cm;
margin-right:0cm;
margin-bottom:8.0pt;
margin-left:0cm;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
h1
{mso-style-priority:9;
mso-style-link:"Rubrik 1 Char";
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:24.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
span.Rubrik1Char
{mso-style-name:"Rubrik 1 Char";
mso-style-priority:9;
mso-style-link:"Rubrik 1";
font-family:"Calibri",sans-serif;
mso-ligatures:none;
mso-fareast-language:SV;
font-weight:bold;}
span.apple-converted-space
{mso-style-name:apple-converted-space;}
span.text-normal
{mso-style-name:text-normal;}
span.E-postmall21
{mso-style-type:personal-compose;
color:black;
font-weight:bold;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;
mso-ligatures:none;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="SV" link="#0563C1" vlink="#954F72" style="word-wrap:break-word">
<div class="WordSection1">
<p class="MsoNormal"><b><span lang="EN-US" style="font-size:24.0pt;line-height:105%;color:black">SmallTalks
</span></b><b><span lang="EN-US" style="font-size:14.0pt;line-height:105%;color:black">[about Nanoscience]</span></b><span lang="EN-US" style="color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span lang="EN-US" style="color:black">On Monday </span></b><b><span lang="EN-US">November 13th
</span></b><span lang="EN-US" style="color:black">at 15.00h</span><span lang="EN-US">
<span style="color:black">we welcome you all to our SmallTalks seminar series. You are welcome to join us in lecture hall <b>Kollektorn, MC2 with fika</b> or on zoom.<o:p></o:p></span></span></p>
<h1><span lang="EN-US" style="font-size:11.0pt;color:black;font-weight:normal">Our speaker is Elin Svensson, Project Assistant, Chemical Biology, Life Sciences. The seminar is titled “Microfluidic platforms to evaluate the performance of nanomedicine in blood</span><span class="text-normal"><span lang="EN-US" style="font-size:11.0pt;font-weight:normal"></span></span><span lang="EN-US" style="font-size:11.0pt;color:black;font-weight:normal">”.</span><span lang="EN-US" style="font-size:11.0pt;font-weight:normal"><o:p></o:p></span></h1>
<p class="MsoNormal"><b><span lang="EN-US" style="color:black">Abstract:<o:p></o:p></span></b></p>
<p class="MsoNormal"><span lang="EN-US" style="color:black">Nanoparticles have the potential to revolutionize medicine by improving drug delivery. For instance, the function of the mRNA-based Covid-19 vaccines was enabled by using lipid nanoparticles. However,
effectively delivering drugs to targeted organs or pathological niches, such as tumors or inflammation sites, remains a key challenge in nanomedicine. This SmallTalk will discuss using a microfluidic platform to construct a more realistic model compared to
existing ones, enabling more accurate estimations of nanomedical behaviour in the human body. The seminar is divided into two parts, where the first part consists of a pure overview of the field and is held on a generally accessible level (10<span class="apple-converted-space"> </span>min).
The second part will be more technical (15-20 minutes).<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align:justify"><span lang="EN-US" style="color:black">Looking forward to seeing you live or on Zoom:
</span><a href="https://chalmers.zoom.us/j/63018620593#success"><span lang="EN-US">https://chalmers.zoom.us/j/63018620593#success</span></a><span style="color:black">
</span><span lang="EN-US" style="color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US" style="color:black">Best regards, <o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US" style="color:black">Alexandra, Philippe, Christoph, and Janine<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US"><o:p> </o:p></span></p>
</div>
</body>
</html>